Scar Clinical Trials

130 recruitingLast updated: June 18, 2026

There are 130 actively recruiting scar clinical trials across 35 countries. Studies span Not Applicable, Phase 2, Phase 3, Phase 4, Phase 1, Early Phase 1. Top locations include Sacramento, California, United States, Cairo, Egypt, London, United Kingdom. Updated daily from ClinicalTrials.gov.


Scar Trials at a Glance

130 actively recruiting trials for scar are listed on ClinicalTrialsFinder across 6 cities in 35 countries. The largest study group is Not Applicable with 67 trials, with the heaviest enrollment activity in Sacramento, Cairo, and London. Lead sponsors running scar studies include Cairo University, Chinese University of Hong Kong, and Sohag University.

Treatments under study

About Scar Clinical Trials

Looking for clinical trials for Scar? There are currently 17 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Scar trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Scar clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 130 trials

Recruiting
Not Applicable

Immune Profile Analysis and Biomarker Identification in Women With Repeated Implantation Failure or Unexplained Recurrent Spontaneous Miscarriage

Recurrent miscarriageImmune SystemRepeated Embryo Implantation Failure
Centre Hospitalier Universitaire, Amiens150 enrolled1 locationNCT05648136
Recruiting
Phase 3

Topical Cryotherapy and Keloid/Hypertrophic Scars

hypertrophic scarsKeloid Scars
Sonal Choudhary30 enrolled1 locationNCT07336368
Recruiting
Not Applicable

1470nm Laser for the Treatment of Androgenetic Alopecia and Scarring Alopecia

Scarring Alopeciaandrogenetic alopecia
Montefiore Medical Center10 enrolled1 locationNCT05460611
Recruiting
Phase 1Phase 2

Scar Remodeling After Burn Injury Using Allogeneic Adipose-derived Stromal Cells

Scar Conditions and Fibrosis of SkinScar Quality Assessment and SafetyScar Tissue
Rigshospitalet, Denmark39 enrolled1 locationNCT07635875
Recruiting
Not Applicable

Impact of Suture Type on Pigment Disturbances in Patients of Skin of Color

Scar
Melissa Pugliano-Mauro34 enrolled3 locationsNCT05408117
Recruiting
Not Applicable

Evaluating the Efficacy of Force Modulating Tissue Bridge Device in Preventing Hypertrophic Scars Following Gender-Affirming Mastectomy

MastectomyGender DysphoriaHypertrophic scar
University of California, San Francisco78 enrolled1 locationNCT07147166
Recruiting
Not Applicable

The Treatment Outcomes of Cesarean Scar Pregnancy

Cesarean Scar Pregnancy
Women's Hospital School Of Medicine Zhejiang University82 enrolled1 locationNCT07608094
Recruiting
Not Applicable

A Multicenter, Prospective, Randomized Controlled Clinical Study on the Effect of Hysteroscopic Uterine Septum Resection on IVF-ET Outcomes in Infertile Patients With Non-recurrent Miscarriage

Infertility and Miscarriage
The Third Xiangya Hospital of Central South University236 enrolled1 locationNCT07611656
Recruiting
Not Applicable

Subcision With Injection of Poly Deoxyribonucleotide Versus Subcision With Injection of Non-cross Linked Hyaluronic Acid in Rolling Acne Scars Treatment.

Atrophic Acne Scars
Cairo University20 enrolled1 locationNCT07547956
Recruiting
Not Applicable

The Role of Pulsed Dye Laser Therapy in the Management of Burn Scars

Burn scar
University of Manitoba6 enrolled1 locationNCT01488240
Recruiting
Not Applicable

The Role of Fractional Vascular Laser Therapy in the Management of Burn Scars

Burn scar
University of Manitoba6 enrolled1 locationNCT01619917
Recruiting

PERIodontal Disease, Microbiota and Miscarriage

MiscarriageParodontitis
University Hospital, Toulouse30 enrolled1 locationNCT06576622
Recruiting
Not Applicable

Microneedling vs Dermabrasion for Early Facial Scar Resurfacing

Scar
Wake Forest University Health Sciences30 enrolled1 locationNCT06171386
Recruiting
Not Applicable

Scar Mobilization Improves Scars and Quality of Life in Burned Children.

Burn scar
Riphah International University15 enrolled1 locationNCT07578883
Recruiting
Not Applicable

Losartan for Corneal Fibrosis

Corneal Scarring Fibrosis
Universidad Autonoma de Nuevo Leon46 enrolled1 locationNCT07449000
Recruiting
Not Applicable

Exososmes in Atrophic Scars Management

Atrophic Scar
Zagazig University12 enrolled1 locationNCT07569666
Recruiting
Phase 2

A Phase II Study of 9MW3811 in Patients With Pathological Scar

Scar
Mabwell (Shanghai) Bioscience Co., Ltd.30 enrolled1 locationNCT07576608
Recruiting
Phase 2Phase 3

Post-Operative Use of FS2 to Mitigate Scarring in Burn Patients

Burn scarBurn Wound
Birch BioMed Inc70 enrolled2 locationsNCT06807021
Recruiting
Not Applicable

Aesthetic Outcome of Tie-over Bolster Application in Surgical Wounds

scarring
University of California, Davis60 enrolled1 locationNCT05758168
Recruiting
Phase 1Phase 2

An Open-label Study to Investigate ECUR-506 in Male Babies Less Than 9 Months of Age With Neonatal Onset OTC Deficiency

Ornithine Transcarbamylase DeficiencyOrnithine Transcarbamylase Deficiency DiseaseUrea Cycle Disorders, Inborn+1 more
iECURE, Inc.20 enrolled12 locationsNCT06255782